Article Name Predictive Diagnostics
Updated guidelines standardise early screening, prevention, and treatment strategies to improve maternal and neonatal outcomes
17th April, 2026
α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies
16th April, 2026
AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency.
16th April, 2026
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research
15th April, 2026
Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy
15th April, 2026
Integrated automated platform unifies multi step sample preparation to improve consistency, reduce operational complexity, and enable high precision workflows across MRD testing and advanced molecular diagnostics
15th April, 2026
Eligible Medicare beneficiaries may receive the WHOOP device and platform, enabling access to a robust technology-enabled care program for improving chronic health
14th April, 2026
The acquisition will strengthen Stryker’s Peripheral Vascular (PV) portfolio by adding revascularisation technology
14th April, 2026
Digital health and clinical platforms can now operationalise Galleri seamlessly through Junction's ordering and diagnostic infrastructure.
10th April, 2026
Expands OEM platform and strengthens leadership in nuclear medicine imaging
03rd April, 2026
The Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion.
30th March, 2026
Collaboration expected to leverage Neurophet AQUA, Neurophet SCALE PET and Neurophet AQUA AD Plus
27th March, 2026
The numbers challenge a deeply rooted cultural habit – to self-diagnose, self-medicate, and wait
27th March, 2026
The disease is primarily caused by the Human Papillomavirus (HPV), with types 16 and 18 accounting for nearly 82 per cent of cases in the country
27th March, 2026
Akrivia Biosciences has introduced a novel framework that redefines how cancer genomes are interpreted
25th March, 2026
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
25th March, 2026
A key milestone in this journey is DeepHealth’s acquisition of Gleamer, which expands its capabilities in X-ray interpretation and automated reporting
23rd March, 2026
This collaboration is a key strategic milestone in the continued expansion of Trinity Biotech’s New York State Department of Health
23rd March, 2026
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer